Risk

5/12/2010
07:07 PM
Connect Directly
Google+
LinkedIn
Twitter
RSS
E-Mail
50%
50%

Canadian Admits Selling Fake Cancer Drugs Online

The scammer faces up to 20 years in prison for wire fraud.

A 22-year-old Canadian man pleaded guilty on Tuesday in Phoenix, Arizona, to selling fake cancer drugs over the Internet.

Hazim Gaber, a resident of Edmonton, Canada, was indicted last year on five counts of wire fraud, according to the Department of Justice. He was arrested in Germany in 2009 and extradited to the U.S.

At his plea hearing, Gaber acknowledged selling what he claimed was the experimental cancer drug sodium dichloroacetate, or DCA, to at least 65 people in the Belgium, Canada, the Netherlands, the U.K., and the U.S.

Court documents state that "DCA is an odorless, inexpensive, relatively non-toxic experimental cancer drug that is highly sought after by cancer patients."

DCA is not approved by the FDA and is only available to patents in clinical trials.

What Gaber provided to customers, however, was not DCA. It was, he acknowledged, various common white powdery substances such as starch, dextrin, dextrose, or lactose.

A Department of Justice spokesperson did not immediately respond to a request for information about the extent to which the cancer patients who took the fake DCA suffered harm as a result of being duped.

Gaber also acknowledged that his Web site, DCAdvice.com, included false claims that the site was the only lawful supplier of DCA and that the site was affiliated with the University of Alberta.

The doctor who published the 2007 study that suggested DCA's effectiveness as a cancer treatment, Evangelos Michelakis, is a professor in the University's Department of Medicine.

In his plea, Gaber also admitted to selling more than 800 copies of pirated business software.

Gaber faces up to 20 years in prison and a fine of $250,000 for each count of wire fraud. His sentencing is scheduled for August 2.

Comment  | 
Print  | 
More Insights
Comments
Newest First  |  Oldest First  |  Threaded View
More Than Half of Users Reuse Passwords
Curtis Franklin Jr., Senior Editor at Dark Reading,  5/24/2018
Is Threat Intelligence Garbage?
Chris McDaniels, Chief Information Security Officer of Mosaic451,  5/23/2018
Register for Dark Reading Newsletters
White Papers
Video
Cartoon Contest
Write a Caption, Win a Starbucks Card! Click Here
Latest Comment: This comment is waiting for review by our moderators.
Current Issue
Flash Poll
[Strategic Security Report] Navigating the Threat Intelligence Maze
[Strategic Security Report] Navigating the Threat Intelligence Maze
Most enterprises are using threat intel services, but many are still figuring out how to use the data they're collecting. In this Dark Reading survey we give you a look at what they're doing today - and where they hope to go.
Twitter Feed
Dark Reading - Bug Report
Bug Report
Enterprise Vulnerabilities
From DHS/US-CERT's National Vulnerability Database
CVE-2018-11487
PUBLISHED: 2018-05-26
PHPMyWind 5.5 has XSS via the cid parameter to newsshow.php, or the query string to news.php or about.php.
CVE-2018-11471
PUBLISHED: 2018-05-25
Cockpit 0.5.5 has XSS via a collection, form, or region.
CVE-2018-11472
PUBLISHED: 2018-05-25
Monstra CMS 3.0.4 has Reflected XSS during Login (i.e., the login parameter to admin/index.php).
CVE-2018-11473
PUBLISHED: 2018-05-25
Monstra CMS 3.0.4 has XSS in the registration Form (i.e., the login parameter to users/registration).
CVE-2018-11474
PUBLISHED: 2018-05-25
Monstra CMS 3.0.4 has a Session Management Issue in the Administrations Tab. A password change at admin/index.php?id=users&action=edit&user_id=1 does not invalidate a session that is open in a different browser.